Cargando…
Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
INTRODUCTION: There are various approaches to the treatment of cutaneous tumors; one of them is treatment with imiquimod, a synthetic toll-like receptor agonist with a low molecular weight that offers a topical, noninvasive, and non-surgical therapeutic option. The main objective of our study was to...
Autores principales: | Alessi, Sabrina Sisto, Sanches, Jose Antonio, de Oliveira, Walmar Roncalli, Messina, Maria Cristina, de Almeida Pimentel, Eugenio Raul, Neto, Cyro Festa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763070/ https://www.ncbi.nlm.nih.gov/pubmed/19841702 http://dx.doi.org/10.1590/S1807-59322009001000005 |
Ejemplares similares
-
Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998) -
High-risk mucosal HPV types associated with squamous cell carcinoma
on the nose tip in an immunocompetent young man
por: Gavioli, Camila Fátima Biancardi, et al.
Publicado: (2018) -
Phaeohyphomycosis in renal transplantation: report of two cases
por: de Oliveira, Walmar Roncalli Pereira, et al.
Publicado: (2016) -
Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009) -
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)